BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 12616495)

  • 1. Lymphoblastoid cells express HLA-B27 homodimers both intracellularly and at the cell surface following endosomal recycling.
    Bird LA; Peh CA; Kollnberger S; Elliott T; McMichael AJ; Bowness P
    Eur J Immunol; 2003 Mar; 33(3):748-59. PubMed ID: 12616495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell-surface expression and immune receptor recognition of HLA-B27 homodimers.
    Kollnberger S; Bird L; Sun MY; Retiere C; Braud VM; McMichael A; Bowness P
    Arthritis Rheum; 2002 Nov; 46(11):2972-82. PubMed ID: 12428240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cutting edge: HLA-B27 can form a novel beta 2-microglobulin-free heavy chain homodimer structure.
    Allen RL; O'Callaghan CA; McMichael AJ; Bowness P
    J Immunol; 1999 May; 162(9):5045-8. PubMed ID: 10227970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLA-B27 polymorphism at position 116 critically influences the association with TAP/tapasin, intracellular trafficking and conformational homodimers formation.
    Blanco-Gelaz MA; Suárez-Alvarez B; Díaz-Peña R; López-Larrea C
    Mol Immunol; 2009 Apr; 46(7):1304-11. PubMed ID: 19167761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Similar cell surface expression of beta2-microglobulin-free heavy chains by HLA-B27 subtypes differentially associated with ankylosing spondylitis.
    Vázquez MN; López de Castro JA
    Arthritis Rheum; 2005 Oct; 52(10):3290-9. PubMed ID: 16200602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exogenous peptide ligand influences the expression and half-life of free HLA class I heavy chains ubiquitously detected at the cell surface.
    Carreno BM; Hansen TH
    Eur J Immunol; 1994 Jun; 24(6):1285-92. PubMed ID: 8206088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HLA-B27.
    Bowness P
    Annu Rev Immunol; 2015; 33():29-48. PubMed ID: 25861975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA-B27 misfolding is associated with aberrant intermolecular disulfide bond formation (dimerization) in the endoplasmic reticulum.
    Dangoria NS; DeLay ML; Kingsbury DJ; Mear JP; Uchanska-Ziegler B; Ziegler A; Colbert RA
    J Biol Chem; 2002 Jun; 277(26):23459-68. PubMed ID: 11978783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spondylarthritis-associated and non-spondylarthritis-associated B27 subtypes differ in their dependence upon tapasin for surface expression and their incorporation into the peptide loading complex.
    Goodall JC; Ellis L; Hill Gaston JS
    Arthritis Rheum; 2006 Jan; 54(1):138-47. PubMed ID: 16385505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The amino acid at position 97 is involved in folding and surface expression of HLA-B27.
    Blanco-Gelaz MA; Suárez-Alvarez B; González S; López-Vázquez A; Martínez-Borra J; López-Larrea C
    Int Immunol; 2006 Jan; 18(1):211-20. PubMed ID: 16361312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formation of HLA-B27 homodimers and their relationship to assembly kinetics.
    Antoniou AN; Ford S; Taurog JD; Butcher GW; Powis SJ
    J Biol Chem; 2004 Mar; 279(10):8895-902. PubMed ID: 14684742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HLA-B27 and the pathogenesis of spondyloarthropathies.
    López de Castro JA
    Immunol Lett; 2007 Jan; 108(1):27-33. PubMed ID: 17129613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HLA-B27 heavy chain homodimers are expressed in HLA-B27 transgenic rodent models of spondyloarthritis and are ligands for paired Ig-like receptors.
    Kollnberger S; Bird LA; Roddis M; Hacquard-Bouder C; Kubagawa H; Bodmer HC; Breban M; McMichael AJ; Bowness P
    J Immunol; 2004 Aug; 173(3):1699-710. PubMed ID: 15265899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An extra molecule in addition to human tapasin is required for surface expression of beta2m linked HLA-B4402 on murine cell.
    Flutter B; Fu HM; Wedderburn L; Gao B
    Mol Immunol; 2007 Jul; 44(14):3528-36. PubMed ID: 17498802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What is the role of HLA-B27 in spondyloarthropathies?
    Chatzikyriakidou A; Voulgari PV; Drosos AA
    Autoimmun Rev; 2011 Jun; 10(8):464-8. PubMed ID: 21296192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HLA B27 in health and disease: a double-edged sword?
    Bowness P
    Rheumatology (Oxford); 2002 Aug; 41(8):857-68. PubMed ID: 12154202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A monoclonal antibody that recognizes HLA-B27 in the context of peptides.
    Wang J; Yu DT; Fukazawa T; Kellner H; Wen J; Cheng XK; Roth G; Williams KM; Raybourne RB
    J Immunol; 1994 Feb; 152(3):1197-205. PubMed ID: 8301124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA-B27: natural function and pathogenic role in spondyloarthritis.
    McMichael A; Bowness P
    Arthritis Res; 2002; 4 Suppl 3(Suppl 3):S153-8. PubMed ID: 12110134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allelic association with ankylosing spondylitis fails to correlate with human leukocyte antigen B27 homodimer formation.
    Lim Kam Sian TCC; Indumathy S; Halim H; Greule A; Cryle MJ; Bowness P; Rossjohn J; Gras S; Purcell AW; Schittenhelm RB
    J Biol Chem; 2019 Dec; 294(52):20185-20195. PubMed ID: 31740583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The biochemistry and immunology of non-canonical forms of HLA-B27.
    Shaw J; Hatano H; Kollnberger S
    Mol Immunol; 2014 Jan; 57(1):52-8. PubMed ID: 23910730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.